Carlos S Moreno

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Cancers

Scientific reports

Molecular cancer research : MCR

Nature biotechnology

Emory University School of Medicine

Emory University Laney Graduate School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Emory University School of Medicine Sep 01 2010

United States

Associate Professor :: Pathology and Laboratory Medicine

Emory University School of Medicine Oct 01 2001 - Aug 31 2010

United States

Assistant Professor :: Pathology and Laboratory Medicine

Charles Stark Draper Laboratory Nov 15 1990 - Jun 15 1992

United States

Aerospace Engineer

NASA Jet Propulsion Laboratory Sep 01 1988 - Nov 01 1990

United States

Space Systems Engineer

Education History

Emory University Laney Graduate School Aug 25 1992 - May 11 1998

United States

PHD :: Genetics and Molecular Biology

Massachusetts Institute of Technology Sep 01 1986 - May 27 1988

United States

MSC :: Aeronautics and Astronautics

Massachusetts Institute of Technology Sep 01 1982 - Jun 02 1986

United States

BSC :: Aeronautics and Astronautics

Publications

Carlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar, Emma R Klein, Ismaheel O Lawal, Olayinka A Abiodun-Ojo, Dattatraya Patil, Benjamin G Barwick, Yijian Huang, David M Schuster, Martin G Sanda, Adeboye O Osunkoya
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. Cancers 15 (23) (2023)
Mert Boya, Tevhide Ozkaya-Ahmadov, Brandi E Swain, Chia-Heng Chu, Norh Asmare, Ozgun Civelekoglu, Ruxiu Liu, Jeong Hoon Lee, Sherry Tobia, Shweta Biliya, L DeEtte McDonald, Bassel Nazha, Omer Kucuk, Martin G Sanda, Benedict B Benigno, Carlos S Moreno, Mehmet A Bilen, John F McDonald, A Fatih Sarioglu
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. Nature communications 13 (1) (2022)
Veronique Ouellet, Andrew Erickson, null null, Kathy Wiley, Colm Morrissey, Viktor Berge, Carlos S Moreno, Kristin Austlid Tasken, Dominique Trudel, Lawrence D True, Michael S Lewis, Aud Svindland, Onur Ertunc, Igor Damasceno Vidal, Adeboye O Osunkoya, Tracy Jones, G Steven Bova, Tarja Lamminen, Ariel H Achtman, Mark Buzza, Michelle M Kouspou, Steven A Bigler, Xinchun Zhou, Stephen J Freedland, Anne-Marie Mes-Masson, Isla P Garraway, Bruce J Trock, Pekka Taimen, Fred Saad, Tuomas K Mirtti, Beatrice S Knudsen, Angelo M DeMarzo
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (4) (2022)
John D Roback, Erika A Tyburski, David Alter, Saja Asakrah, Ann Chahroudi, Annette Esper, Sarah Farmer, Janet Figueroa, Jennifer K Frediani, Mark D Gonzalez, David S Gottfried, Jeannette Guarner, Nitika A Gupta, Stacy S Heilman, Charles E Hill, Robert Jerris, Russell R Kempker, Jessica Ingersoll, Joshua M Levy, Maud Mavigner, Carlos S Moreno, Claudia R Morris, Eric J Nehl, Andrew S Neish, Deniz Peker, Natia Saakadze, Paulina A Rebolledo, Christina A Rostad, Nils Schoof, Allie Suessmith, Julie Sullivan, Yun F Wayne Wang, Anna Wood, Miriam B Vos, Oliver Brand, Greg S Martin, Wilbur A Lam
The need for new test verification and regulatory support for innovative diagnostics. Nature biotechnology 39 (9) (2021)
Zachary S Buchwald, Sibo Tian, Michael Rossi, Geoffrey H Smith, Jeffrey Switchenko, Jennifer E Hauenstein, Carlos S Moreno, Robert H Press, Roshan S Prabhu, Jim Zhong, Debra F Saxe, Stewart G Neill, Jeffrey J Olson, Ian R Crocker, Walter J Curran, Hui-Kuo G Shu
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma. Scientific reports 10 (1) (2020)
Angela Ogden, Shristi Bhattarai, Bikram Sahoo, Nigel Patrick Mongan, Mansour Alsaleem, Andrew R Green, Mohammed Aleskandarany, Ian O Ellis, Sonal Pattni, Xiaoxian Bill Li, Carlos S Moreno, Uma Krishnamurti, Emiel A Janssen, Kristin Jonsdottir, Emad Rakha, Padmashree Rida, Ritu Aneja
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers. Scientific reports 10 (1) (2020)
Allyson E Koyen, Matthew Z Madden, Dongkyoo Park, Elizabeth V Minten, Priya Kapoor-Vazirani, Erica Werner, Neil T Pfister, Ramona Haji-Seyed-Javadi, Hui Zhang, Jie Xu, Nikita Deng, Duc M Duong, Turner J Pecen, Zoë Frazier, Zachary D Nagel, Jean-Bernard Lazaro, Kent W Mouw, Nicholas T Seyfried, Carlos S Moreno, Taofeek K Owonikoko, Xingming Deng, David S Yu
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair. Oncogene 39 (25) (2020)
Sanjay Chandrasekaran, Maiko Sasaki, Christopher D Scharer, Haydn T Kissick, Dillon G Patterson, Kelly R Magliocca, John T Seykora, Bishu Sapkota, David A Gutman, Lee A D Cooper, Gregory B Lesinski, Edmund K Waller, Susan N Thomas, Sergei V Kotenko, Jeremy M Boss, Carlos S Moreno, Robert A Swerlick, Brian P Pollack
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression. Molecular cancer research : MCR 17 (12) (2019)
Nitya V Sharma, Kathryn L Pellegrini, Veronique Ouellet, Felipe O Giuste, Selvi Ramalingam, Kenneth Watanabe, Eloise Adam-Granger, Lucresse Fossouo, Sungyong You, Michael R Freeman, Paula Vertino, Karen Conneely, Adeboye O Osunkoya, Dominique Trudel, Anne-Marie Mes-Masson, John A Petros, Fred Saad, Carlos S Moreno
Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer. Cancers 10 (10) (2018)
Sahar Harati, Lee A D Cooper, Josue D Moran, Felipe O Giuste, Yuhong Du, Andrei A Ivanov, Margaret A Johns, Fadlo R Khuri, Haian Fu, Carlos S Moreno
MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development. PloS one 12 (1) (2017)

Carlos S Moreno.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos S Moreno